New perspectives in cancer immunotherapy: targeting IL-6 cytokine family
Chronic inflammation has been recognized as a canonical cancer hallmark. It is orchestrated by cytokines, which are master regulators of the tumor microenvironment (TME) as they represent the main communication bridge between cancer cells, the tumor stroma, and the immune system. Interleukin (IL)-6...
Saved in:
| Main Authors: | Maria Florencia Soler, Andrea Abaurrea, Peio Azcoaga, Angela M Araujo, Maria M Caffarel |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2023-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/11/11/e007530.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IL-12 family cytokines and autoimmune diseases: A potential therapeutic target?
by: Xiaoyu Cui, et al.
Published: (2025-06-01) -
The role of IL-17 family cytokines in cardiac fibrosis
by: Liqing Huang
Published: (2024-10-01) -
Fibrosis Related Inflammatory Mediators: Role of the IL-10 Cytokine Family
by: Erna Sziksz, et al.
Published: (2015-01-01) -
Regulation of Antitumor Immune Responses by the IL-12 Family Cytokines, IL-12, IL-23, and IL-27
by: Mingli Xu, et al.
Published: (2010-01-01) -
Proinflammatory cytokines VEGFA, IL-6, IL-8 as markers of hepatotoxicity after COVID-19
by: M. A. Urevskii, et al.
Published: (2023-06-01)